Our results also support the hypothesis that MDR-1 may at the very least be a marker of aggressive tumors [78], as we consistently observe at least MDR-1 or BCRP protein expression in all tumors samples obtained from human breast cancer patients and canines with lymphoma that failed chemotherapy [80]. The gene discussed is ABCB1; the disease is breast carcinoma.